Voxel-based analysis of amyloid-burden measured with [11c]pib pet in a double transgenic mouse model of alzheimer's disease

Molecular Imaging and Biology

Volumn 15, Issue 5, 2013, Pages 576-584

  Von Reutern, Boris ^a,b   Grünecker, Barbara ^c   Yousefi, Behrooz H ^b,d   Henriksen, Gjermund ^b   Czisch, Michael ^c   Drzezga, Alexander ^b,e  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Double transgenic; Magnetic resonance imaging; Mouse model; Pittsburgh compound B; Positron emission tomography; Presenilin 1; Statistical parametric mapping; Voxel based

Indexed keywords

AMYLOID BETA PROTEIN; PITTSBURGH COMPOUND B;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOMATION; BRAIN CORTEX; BRAIN MAPPING; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG RETENTION; FEMALE; HIPPOCAMPUS; HISTOPATHOLOGY; MALE; MOUSE; NEUROIMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; RADIOLOGICAL PARAMETERS; REGRESSION ANALYSIS; TRANSGENIC MOUSE; VALIDATION PROCESS; VOXEL BASED ANALYSIS;

ANIMALIA; MUS; MUS MUSCULUS;

ALZHEIMER DISEASE; AMYLOID; ANIMALS; BENZOTHIAZOLES; CARBON RADIOISOTOPES; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; MICE, TRANSGENIC; PLAQUE, AMYLOID; POSITRON-EMISSION TOMOGRAPHY; REGRESSION ANALYSIS; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 84885313373     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-013-0625-z     Document Type: Article

References (36)

1. Klunk WE, Engler H, Nordberg A et al (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55:306-19
2. Shoghi-Jadid K, Small GW, Agdeppa ED et al (2002) Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry 10:24-35
3. Verhoeff NP, Wilson AA, Takeshita S et al (2004) In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. Am J Geriatr Psychiatry 12:584-95
4. Ikonomovic MD, Klunk WE, Abrahamson EE et al (2008) Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain 131:1630-45
5. Leinonen V, Alafuzoff I, Aalto S et al (2008) Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Arch Neurol 65:1304-9
6. Sojkova J, Driscoll I, Iacono D et al (2011) In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults. Arch Neurol 68:232-40
7. Maeda J, Ji B, Irie T et al (2007) Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography. J Neurosci 27:10957-68
8. Manook A, Yousefi BH, Willuweit A et al (2012) Small-animal PET imaging of amyloid-beta plaques with [C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease. PLoS One 7:e31310
9. Klunk WE, Lopresti BJ, Ikonomovic MD et al (2005) Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci 25:10598-606
10. Toyama H, Ye D, Ichise M et al (2005) PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease. Eur J Nucl Med Mol Imaging 32:593-600
11. Yousefi BH, Manook A, Drzezga A et al (2011) Synthesis and evaluation of 11C-labeled imidazo[2,1-b]benzothiazoles (IBTs) as PET tracers for imaging beta-amyloid plaques in Alzheimer's disease. J Med Chem 54:949-56
12. Price JC, Klunk WE, Lopresti BJ et al (2005) Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab 25:1528-47
13. Kemppainen NM, Aalto S, Wilson IA et al (2006) Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease. Neurology 67:1575-80
14. Ziolko SK, Weissfeld LA, Klunk WE et al (2006) Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease. NeuroImage 33:94-102
15. Mikhno A, Devanand D, Pelton G et al (2008) Voxel-based analysis of 11C-PIB scans for diagnosing Alzheimer's disease. J Nucl Med 49:1262-9
16. Kemppainen NM, Aalto S, Wilson IA et al (2007) PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology 68:1603-6
17. Grimmer T, Henriksen G, Wester HJ et al (2009) Clinical severity of Alzheimer's disease is associated with PIB uptake in PET. Neurobiol Aging 30:1902-9
18. Shin J, Lee SY, Kim SJ et al (2010) Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG. NeuroImage 52:488-96
19. Scheinin NM, Aalto S, Koikkalainen J et al (2009) Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls. Neurology 73:1186-92
20. Edison P, Archer HA, Gerhard A et al (2008) Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol Dis 32:412-9
21. Jack CR Jr, Lowe VJ, Senjem ML et al (2008) 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 131:665-80
22. Dubois A, Herard AS, Delatour B et al (2010) Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP/PS1 transgenic mouse model of Alzheimer's disease. NeuroImage 51:586-98
23. Hooker JM, Patel V, Kothari S, Schiffer WK (2009) Metabolic changes in the rodent brain after acute administration of salvinorin A. Mol Imaging Biol 11:137-43
24. Prieto E, Collantes M, Delgado M et al (2011) Statistical parametric maps of (1)(8)F-FDG PET and 3-D autoradiography in the rat brain: A cross-validation study. Eur J Nucl Med Mol Imaging 38:2228-37
25. Casteels C, Bormans G, Van Laere K (2010) The effect of anaesthesia on [(18)F]MK-9470 binding to the type 1 cannabinoid receptor in the rat brain. Eur J Nucl Med Mol Imaging 37:1164-73
26. Casteels C, Lauwers E, Baitar A et al (2010) In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease. Brain Res 1316:153-62
27. Willuweit A, Velden J, Godemann R et al (2009) Early-onset and robust amyloid pathology in a new homozygous mouse model of Alzheimer's disease. PLoS One 4:e7931
28. Bacskai BJ, Hickey GA, Skoch J et al (2003) Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice. Proc Natl Acad Sci U S A 100:12462-7
29. Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates. Academic Press, San Diego
30. Sawiak SJ, Wood NI, Williams GB et al (2009) Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry. Neurobiol Dis 33:20-7
31. Brammer DW, Riley JM, Kreuser SC et al (2007) Harderian gland adenectomy: a method to eliminate confounding radio-opacity in the assessment of rat brain metabolism by 18F-fluoro-2-deoxy-D-glucose positron emission tomography. J Am Assoc Lab Anim Sci 46:42-5
32. Fukuyama H, Hayashi T, Katsumi Y et al (1998) Issues in measuring glucose metabolism of rat brain using PET: the effect of harderian glands on the frontal lobe. Neurosci Lett 255:99-102
33. Kuge Y, Kawashima H, Yamazaki S et al (1996) [1-11C]octanoate as a potential PET tracer for studying glial functions: PET evaluation in rats and cats. Nucl Med Biol 23:1009-12
34. Kuge Y, Minematsu K, Hasegawa Y et al (1997) Positron emission tomography for quantitative determination of glucose metabolism in normal and ischemic brains in rats: An insoluble problem by the Harderian glands. J Cereb Blood Flow Metab 17:116-20
35. Mevel K, Desgranges B, Baron JC et al (2007) Detecting hippocampal hypometabolism in mild cognitive impairment using automatic voxel-based approaches. NeuroImage 37:18-25
36. Nestor PJ, Fryer TD, Smielewski P, Hodges JR (2003) Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann Neurol 54:343-51